Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
84.47
-0.43 (-0.51%)
At close: May 15, 2026, 4:00 PM EDT
84.43
-0.04 (-0.05%)
Pre-market: May 18, 2026, 7:54 AM EDT
Abbott Laboratories Employees
Abbott Laboratories had 115,000 employees as of December 31, 2025. The number of employees increased by 1,000 or 0.88% compared to the previous year.
Employees
115,000
Change (1Y)
1,000
Growth (1Y)
0.88%
Revenue / Employee
$392,470
Profits / Employee
$54,365
Market Cap
147.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 115,000 | 1,000 | 0.88% |
| Dec 31, 2024 | 114,000 | 0 | - |
| Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
| Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
| Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
| Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
| Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
| Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
| Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
| Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
| Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
| Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
| Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
| Dec 31, 2012 | 91,000 | 0 | - |
| Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
| Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
| Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
| Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
| Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
| Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
| Dec 31, 2005 | 59,735 | -865 | -1.43% |
| Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
| Dec 31, 2003 | 72,200 | 381 | 0.53% |
| Dec 31, 2002 | 71,819 | 393 | 0.55% |
| Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
| Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
| Dec 31, 1999 | 57,100 | 864 | 1.54% |
| Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
| Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
| Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
| Dec 31, 1995 | 50,241 | 777 | 1.57% |
| Dec 31, 1994 | 49,464 | -195 | -0.39% |
| Dec 31, 1993 | 49,659 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Medtronic | 95,000 |
| Koninklijke Philips | 65,340 |
| Boston Scientific | 59,000 |
| Stryker | 56,000 |
| GE HealthCare Technologies | 54,000 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| Smith & Nephew | 16,988 |
ABT News
- 3 days ago - Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks. - Barrons
- 19 days ago - Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform - PRNewsWire
- 22 days ago - Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 - PRNewsWire
- 4 weeks ago - New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test - PRNewsWire
- 4 weeks ago - Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales - WSJ
- 4 weeks ago - Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting. - Barrons
- 4 weeks ago - Abbott first-quarter results beat on cancer diagnostics, medical device strength - Reuters
- 4 weeks ago - Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences - PRNewsWire